Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | asparaginyl-tRNA synthetase, putative | 0.0021 | 0.0452 | 0.351 |
Echinococcus granulosus | glutaminyl tRNA synthetase | 0.0054 | 0.3789 | 1 |
Plasmodium falciparum | isoleucine--tRNA ligase, putative | 0.0029 | 0.1287 | 0.1287 |
Loa Loa (eye worm) | glutaminyl-tRNA synthetase | 0.0075 | 0.5981 | 1 |
Leishmania major | isoleucyl-tRNA synthetase, putative | 0.0029 | 0.1287 | 1 |
Mycobacterium ulcerans | formamidopyrimidine-DNA glycosylase | 0.0104 | 0.8927 | 1 |
Echinococcus granulosus | isoleucyl tRNA synthetase, cytoplasmic | 0.0029 | 0.1287 | 0.2049 |
Entamoeba histolytica | glutaminyl-tRNA synthetase, putative | 0.0038 | 0.2193 | 1 |
Toxoplasma gondii | isoleucyl-tRNA synthetase family protein | 0.0029 | 0.1287 | 1 |
Mycobacterium ulcerans | formamidopyrimidine-DNA glycosylase | 0.0104 | 0.8927 | 1 |
Plasmodium vivax | isoleucine--tRNA ligase, putative | 0.0029 | 0.1287 | 1 |
Trypanosoma cruzi | asparaginyl-tRNA synthetase, putative | 0.0021 | 0.0452 | 0.351 |
Mycobacterium tuberculosis | Probable formamidopyrimidine-DNA glycosylase Fpg (FAPY-DNA glycosylase) | 0.0104 | 0.8927 | 1 |
Trypanosoma brucei | asparaginyl-tRNA synthetase, putative | 0.0021 | 0.0452 | 0.351 |
Trichomonas vaginalis | glutaminyl-tRNA synthetase, putative | 0.0038 | 0.2193 | 1 |
Echinococcus multilocularis | glutaminyl tRNA synthetase | 0.0054 | 0.3789 | 1 |
Onchocerca volvulus | 0.0023 | 0.0643 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0031 | 0.1448 | 0.1508 |
Mycobacterium tuberculosis | Possible DNA glycosylase | 0.0104 | 0.8927 | 1 |
Loa Loa (eye worm) | isoleucyl-tRNA synthetase | 0.0029 | 0.1287 | 0.1207 |
Trypanosoma brucei | isoleucyl-tRNA synthetase, putative | 0.0029 | 0.1287 | 1 |
Brugia malayi | glutaminyl-tRNA synthetase | 0.0075 | 0.5981 | 1 |
Trypanosoma cruzi | isoleucyl-tRNA synthetase, putative | 0.0029 | 0.1287 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.1287 | 0.1207 |
Chlamydia trachomatis | isoleucine--tRNA ligase | 0.0029 | 0.1287 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | formamidopyrimidine-DNA glycosylase | 0.0104 | 0.8927 | 1 |
Treponema pallidum | isoleucyl-tRNA synthetase | 0.0029 | 0.1287 | 0.5 |
Giardia lamblia | Glutaminyl-tRNA synthetase | 0.0038 | 0.2193 | 1 |
Mycobacterium leprae | Probable formamidopyrimidine-DNA glycosylase Fpg (FAPY-DNA GLYCOSYLASE) | 0.0104 | 0.8927 | 1 |
Schistosoma mansoni | glutaminyl-tRNA synthetase (glutamine--tRNA ligase) (glnrs) | 0.0054 | 0.3789 | 1 |
Echinococcus multilocularis | isoleucyl tRNA synthetase, cytoplasmic | 0.0029 | 0.1287 | 0.2049 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | = 10 uM | Growth inhibitory activity against PaCa-2 human solid tumor cell line using MTT assay | ChEMBL. | 12139465 |
GI50 (functional) | = 10 uM | Growth inhibitory activity against UMUC3 human solid tumor cell line using MTT assay | ChEMBL. | 12139465 |
GI50 (functional) | = 10 uM | Growth inhibitory activity against PaCa-2 human solid tumor cell line using MTT assay | ChEMBL. | 12139465 |
GI50 (functional) | = 10 uM | Growth inhibitory activity against UMUC3 human solid tumor cell line using MTT assay | ChEMBL. | 12139465 |
GI50 (functional) | = 12 uM | Growth inhibitory activity against A498-2LM human solid tumor cell line using MTT assay | ChEMBL. | 12139465 |
GI50 (functional) | = 12 uM | Growth inhibitory activity against A498-2LM human solid tumor cell line using MTT assay | ChEMBL. | 12139465 |
GI50 (functional) | = 13 uM | Growth inhibitory activity against human MDA-231 cell line using MTT assay. | ChEMBL. | 12139465 |
GI50 (functional) | = 13 uM | Growth inhibitory activity against human MDA-231 cell line using MTT assay. | ChEMBL. | 12139465 |
GI50 (functional) | = 14 uM | Growth inhibitory activity against human PC-3 cell line using MTT assay. | ChEMBL. | 12139465 |
GI50 (functional) | = 14 uM | Growth inhibitory activity against human PC-3 cell line using MTT assay. | ChEMBL. | 12139465 |
GI50 (functional) | = 15 uM | Growth inhibitory activity against HT-29 human solid tumor cell line using MTT assay | ChEMBL. | 12139465 |
GI50 (functional) | = 15 uM | Growth inhibitory activity against HT-29 human solid tumor cell line using MTT assay | ChEMBL. | 12139465 |
GI50 (functional) | = 45 uM | Growth inhibitory activity against A549 human solid tumor cell line using MTT assay | ChEMBL. | 12139465 |
GI50 (functional) | = 45 uM | Growth inhibitory activity against A549 human solid tumor cell line using MTT assay | ChEMBL. | 12139465 |
k cat (binding) | = 4.9 s-1 | Kinetic parameter Kcat of the compound was reported against DT-diaphorase | ChEMBL. | 12139465 |
k cat (binding) | = 4.9 s-1 | Kinetic parameter Kcat of the compound was reported against DT-diaphorase | ChEMBL. | 12139465 |
Km (binding) | = 2.8 uM | Ability of compound to act as substrate for human DT-diaphorase (DTD) was determined, expressed as kinetic parameter KM | ChEMBL. | 12139465 |
Km (binding) | = 2.8 uM | Ability of compound to act as substrate for human DT-diaphorase (DTD) was determined, expressed as kinetic parameter KM | ChEMBL. | 12139465 |
LC99 (functional) | > 100 uM | Inhibitory concentration that reduces clonogenic survival by 2 log units (99%) 2-hour after drug treatment in HT-29 human colon carcinoma cell line. | ChEMBL. | 12139465 |
LC99 (functional) | > 100 uM | Inhibitory concentration that reduces clonogenic survival by 2 log units (99%) 2-hour after drug treatment in BE human colon carcinoma cell line. | ChEMBL. | 12139465 |
LC99 (functional) | > 100 uM | Inhibitory concentration that reduces clonogenic survival by 2 log units (99%) 2-hour after drug treatment in HT-29 human colon carcinoma cell line. | ChEMBL. | 12139465 |
LC99 (functional) | > 100 uM | Inhibitory concentration that reduces clonogenic survival by 2 log units (99%) 2-hour after drug treatment in BE human colon carcinoma cell line. | ChEMBL. | 12139465 |
NA (functional) | 0 | Selectivity ratio of LC99 of BE to LC99 of HT-29; Not applicable | ChEMBL. | 12139465 |
T1/2 (ADMET) | = 659 min | Half life of the compound was determined in presence of sodium dimethyldithiocarbamate | ChEMBL. | 12502368 |
T1/2 (ADMET) | = 716 min | Half life of the compound was determined in presence of glutathione | ChEMBL. | 12502368 |
Vmax (binding) | = 0.045 uM s-1 | Kinetic parameter Vmax of the compound was reported against DT-diaphorase | ChEMBL. | 12139465 |
Vmax (binding) | = 0.045 uM s-1 | Kinetic parameter Vmax of the compound was reported against DT-diaphorase | ChEMBL. | 12139465 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.